A randomized comparison of sibrafiban, an oral glycoprotein (GP) IIb/IIIa receptor antagonist, with and without aspirin versus aspirin after acute coronary syndromes (ACS): Results of the second symphony trial

Published

Journal Article (Academic article)

Full Text

Duke Authors

Cited Authors

  • Newby, LK

Published Date

  • July 1, 2000

Published In

Volume / Issue

  • 36 / 1

Start / End Page

  • 319 - 320

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0735-1097

Language

  • English